Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples